ChronoFast: Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans

Sponsor
German Institute of Human Nutrition (Other)
Overall Status
Recruiting
CT.gov ID
NCT04351672
Collaborator
Charite University, Berlin, Germany (Other), Immanuel Krankenhaus Berlin, Germany (Other), Hasso-Plattner Institut, Potsdam, Germany (Other), University of Potsdam (Other)
30
1
2
35.1
0.9

Study Details

Study Description

Brief Summary

This human dietary intervention study with a cross-over design aims to compare the effects of two isocaloric diets - early time-restricted feeding (TRF) vs. late TRF - on glycemic control and lipid metabolism in overweight and obese women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Early Time-Restricted Feeding
  • Behavioral: Late Time-Restricted Feeding
N/A

Detailed Description

The participants are randomly allocated to one of two study groups: In study group (A) participants will begin with the early TRF (e-TRF) intervention. They will consume their habitual food (and the habitual daily amount of food) between 8 am and 4 pm for two weeks. After a washout-phase participants will conduct the late TRF (l-TRF) and consume their habitual food between 1 pm and 9 pm for another two weeks. Study group (B) receives the same interventions in the reversed order. Both dietary regimens will result in 8-hr eating period and 16-hr fasting period during the 24h day.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans
Actual Study Start Date :
Mar 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Early Time-Restricted Feeding

Behavioral: Early Time-Restricted Feeding
Eat between 8 am and 4 pm for two weeks
Other Names:
  • Early TRF
  • eTRF
  • Experimental: Late Time-Restricted Feeding

    Behavioral: Late Time-Restricted Feeding
    Eat between 1 pm and 9 pm for two weeks
    Other Names:
  • Late TRF
  • lTRF
  • Outcome Measures

    Primary Outcome Measures

    1. Insulin sensitivity [2 weeks]

      Assessed using Matsuda index in oral glucose tolerance test (OGTT)

    Secondary Outcome Measures

    1. Glucose tolerance, fasting glucose, and overall daily glycemic variation [1-2 weeks]

      Assessed by glucose area under the curve in OGTT and using a continuous glucose monitoring system

    2. Metabolic hormones and inflammatory markers [2 weeks]

      Levels of hormones related to the glucose metabolism, hormones of appetite regulation, adipokines and inflammatory markers

    3. Blood lipids [2 weeks]

      Total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides

    4. Satiety and hunger scores [2 weeks]

      Assessed using Visual Analog Scales (VAS with a scale of 1-100, where higher values correspond to stronger satiety/hunger)

    5. Sleep quality and duration [1-2 weeks]

      Assessed by the Pittsburgh Sleep Quality Index (PSQI score, which ranges from 0-21, where higher values correspond to worse sleep quality) and also monitored by an ActiGraph device

    6. Physical activity [7 days]

      24-h physical activity will be monitored by an ActiGraph device

    7. Expression of metabolic genes in adipose tissue [2 weeks]

      RNA-Seq analysis of subcutaneous adipose tissue samples

    8. Social and economic decision behaviour [2 weeks]

      Assessed by computer tests together with the Barratt Impulsiveness Scale short version (BIS-15 with a score between 15 and 60, where higher values correspond to higher impulsiveness) and the UCLA Loneliness Scale (with a score between 20 and 100, where higher values correspond to higher subjectively perceived loneliness)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • BMI 25-35 kg/m²
    Exclusion Criteria:
    • prior diagnosis of type 1 or 2 diabetes

    • weight changes > 5% within past 3 months

    • current shift work or history of shift work

    • traveled across more than one time zone one month before the study

    • poor quality of sleep (PSQI score>10)

    • eating disorders, food intolerance/allergy, severe indigestion

    • Pregnant or breastfeeding

    • severe internal or psychiatric disorders or other conditions that might influence the outcome of the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 German Institute of Human Nutrition Potsdam-Rehbruecke Nuthetal Germany 14558

    Sponsors and Collaborators

    • German Institute of Human Nutrition
    • Charite University, Berlin, Germany
    • Immanuel Krankenhaus Berlin, Germany
    • Hasso-Plattner Institut, Potsdam, Germany
    • University of Potsdam

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Olga Ramich (formerly Pivovarova), project director, German Institute of Human Nutrition
    ClinicalTrials.gov Identifier:
    NCT04351672
    Other Study ID Numbers:
    • DFG RA 3340/3-1
    First Posted:
    Apr 17, 2020
    Last Update Posted:
    May 20, 2021
    Last Verified:
    May 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Olga Ramich (formerly Pivovarova), project director, German Institute of Human Nutrition
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 20, 2021